Use of smoking cessation pharmacotherapies during pregnancy is not associated with increased risk of adverse pregnancy outcomes: a population-based cohort study

BACKGROUND: Varenicline, bupropion and nicotine replacement therapy (NRT) are three effective pharmacotherapies for smoking cessation, but data about their safety in pregnancy are limited. We assessed the risk of adverse perinatal outcomes and major congenital anomalies associated with the use of th...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Med
Autori principali: Tran, Duong Thuy, Preen, David B., Einarsdottir, Kristjana, Kemp-Casey, Anna, Randall, Deborah, Jorm, Louisa R., Choi, Stephanie K. Y., Havard, Alys
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2020
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7001233/
https://ncbi.nlm.nih.gov/pubmed/32019533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-019-1472-9
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi